Guest guest Posted December 9, 2008 Report Share Posted December 9, 2008 How unusual cells may hold key to HIV control Rare people who manage to control HIV on their own are offering new insights into how the immune system kills infected cells. http://www.world-science.net/exclusives/081204_hiv Rare people who manage to control HIV on their own are offering new insights into how the immune system eliminates virus-infected cells, researchers say. A study identifies specific qualities of the immune cells that successfully destroy infected cells and may drive strategies for developing new HIV vaccines and therapies. The rare individuals dubbed “long-term nonprogressors†are able to contain HIV, the virus behind AIDS, for many years without treatment. Evidence suggests certain virus-specific immune cells, called CD8+ T cells, confer this ability by destroying virus-infected cells†" but how remains unknown, said senior study author Mark Connors of the National Institute of Allergy and Infectious Disease in Bethesda, Md. Using new tools that precisely measure these cells’ killing capacity, Connors and colleagues compared how cells from progressors non-progressors battle the virus. The CD8+ T cells of nonprogressors clobbered infected cells by successfully dispensing protein molecules onto them which poked holes in their protective membranes, the researchers found. The immune cells subsequently delivered a deadly molecule called granzyme B to the compromised cells. The CD8+ T cells of progressors accomplished this process poorly, investigators found. But these diminished abilities were reversible after treatment with certain compounds, including phorbol ester and calcium ionophore, suggesting possible therapeutic strategies, they added. The findings could also “be an extremely important milestone for HIV vaccine research,†said es, lead author of the study, published in the Dec. 4 issue of the research journal Immunity. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 10, 2008 Report Share Posted December 10, 2008 Here is another way to control HIV: http://tinyurl.com/ldn-for-hiv-aids How unusual cells may hold key to HIV control How unusual cells may hold key to HIV control Rare people who manage to control HIV on their own are offering new insights into how the immune system kills infected cells. http://www.world-science.net/exclusives/081204_hiv Rare people who manage to control HIV on their own are offering new insights into how the immune system eliminates virus-infected cells, researchers say. A study identifies specific qualities of the immune cells that successfully destroy infected cells and may drive strategies for developing new HIV vaccines and therapies. The rare individuals dubbed “long-term nonprogressors†are able to contain HIV, the virus behind AIDS, for many years without treatment. Evidence suggests certain virus-specific immune cells, called CD8+ T cells, confer this ability by destroying virus-infected cells� " but how remains unknown, said senior study author Mark Connors of the National Institute of Allergy and Infectious Disease in Bethesda, Md. Using new tools that precisely measure these cells’ killing capacity, Connors and colleagues compared how cells from progressors non-progressors battle the virus. The CD8+ T cells of nonprogressors clobbered infected cells by successfully dispensing protein molecules onto them which poked holes in their protective membranes, the researchers found. The immune cells subsequently delivered a deadly molecule called granzyme B to the compromised cells. The CD8+ T cells of progressors accomplished this process poorly, investigators found. But these diminished abilities were reversible after treatment with certain compounds, including phorbol ester and calcium ionophore, suggesting possible therapeutic strategies, they added. The findings could also “be an extremely important milestone for HIV vaccine research,†said es, lead author of the study, published in the Dec. 4 issue of the research journal Immunity. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.